Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn New India Regulatory News (ANII)

Share Price Information for Abrdn New India (ANII)

Share Price is delayed by 15 minutes
Get Live Data
674.00    12.00 (1.81%)
Bid:
656.00
Ask:
674.00
Spread: 18.00 (2.744%)
Market Cap: £292.10m
ANII Live PriceLast checked at - London Stock Exchange

Intraday Abrdn New India Share Chart

Directorate Changes

1 Apr 2026 07:00

RNS Number : 9243Y
Aberdeen New India Investment Trust
01 April 2026
Β 

ABERDEEN NEW INDIA INVESTMENT TRUST PLC

LEI - 549300D2AW66WYEVKF02

Β 

Β 

1 April 2026

Β 

Appointment of Non-Executive Director

Β 

The Board of Aberdeen New India Investment Trust PLC (the "Company") is pleased to announce the appointment of Francesca Ecsery as an independent non-executive Director of the Company with effect from 1 April 2026 following a search conducted by an independent recruitment consultancy.

Β 

Francesca Ecsery has over 30 years' experience working in both blue-chip companies and start-ups and has special expertise in multiplatform consumer marketing, branding and commercial strategies. She is a non-executive director of Haffner Energy S.A., Air France S.A. and Henderson High Income Trust plc.

Β 

Francesca was previously a non-executive director at F&C Investment Trust PLC, the Association of Investment Companies (AIC), Marshall Motor Holdings PLC, Share PLC and Good Energy Group PLC and has held various senior positions in consumer-focused industries including the digital, retail and leisure and travel sectors. Her previous executive roles include McKinsey, PepsiCo, Thorn EMI, Thomas Cook and STA Travel.

Β 

There are no other disclosures required to be made for Francesca Ecsery in respect of paragraphs UKLR 6.4.8R (1) - (6) of the Financial Conduct Authority's Listing Rules.

Β 

Francesca Ecsery, or her persons closely associated, has no interest in the shares of the Company.

Β 

Appointment of Chairman and Senior Independent Director

Β 

As set out in the Annual Report for the year ended 31 March 2025, Michael Hughes retired as Chairman of the Board and as a Director of the Company on 31 March 2026.

Β 

With effect from 1 April 2026, David Simpson is appointed Chairman of the Board, Andrew Robson is appointed Senior Independent Director and Irina Miklavchich is appointed Chair of the Management Engagement Committee.

Β 

Β 

For further information, please contact:

Β 

Stuart Reid

abrdn Holdings Limited

Secretaries

Β 

Email:Β  cef.cosec@aberdeenplc.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAJBMFTMTBJBRF
Date   Source Headline
10th Dec 202410:31 amRNSDoc re. Half Yearly Report
9th Dec 20245:23 pmRNSTransaction in Own Shares
9th Dec 20242:09 pmRNSGearing disclosure
9th Dec 202412:52 pmRNSNet Asset Value(s)
6th Dec 20245:07 pmRNSTransaction in Own Shares
6th Dec 20241:43 pmRNSNet Asset Value(s)
5th Dec 20245:29 pmRNSTransaction in Own Shares
5th Dec 20243:21 pmRNSMonth End Net Asset Value(s)
5th Dec 202412:21 pmRNSNet Asset Value(s)
4th Dec 20245:20 pmRNSTransaction in Own Shares
4th Dec 20241:06 pmRNSNet Asset Value(s)
3rd Dec 20245:23 pmRNSTransaction in Own Shares
3rd Dec 202412:11 pmRNSNet Asset Value(s)
2nd Dec 20245:21 pmRNSTransaction in Own Shares
2nd Dec 20243:05 pmRNSGearing disclosure
2nd Dec 20249:57 amRNSTotal Voting Rights
29th Nov 20245:12 pmRNSTransaction in Own Shares
29th Nov 202412:42 pmRNSNet Asset Value(s)
28th Nov 202412:31 pmRNSNet Asset Value(s)
28th Nov 20247:00 amRNSHalf-Yearly Financial Report
27th Nov 202412:12 pmRNSNet Asset Value(s)
26th Nov 20245:09 pmRNSTransaction in Own Shares
26th Nov 202412:57 pmRNSNet Asset Value(s)
25th Nov 20245:21 pmRNSTransaction in Own Shares
25th Nov 20243:46 pmRNSGearing Disclosures
25th Nov 202412:40 pmRNSNet Asset Value(s)
22nd Nov 20245:18 pmRNSTransaction in Own Shares
22nd Nov 202412:20 pmRNSNet Asset Value(s)
21st Nov 20245:15 pmRNSTransaction in Own Shares
21st Nov 202412:33 pmRNSNet Asset Value(s)
20th Nov 20245:20 pmRNSTransaction in Own Shares
20th Nov 20242:30 pmRNSDirectorate Change
20th Nov 202412:13 pmRNSNet Asset Value(s)
19th Nov 20245:27 pmRNSTransaction in Own Shares
19th Nov 20241:08 pmRNSNet Asset Value(s)
18th Nov 20245:19 pmRNSTransaction in Own Shares
18th Nov 20241:46 pmRNSGearing disclosure
18th Nov 20241:19 pmRNSNet Asset Value(s)
15th Nov 20245:33 pmRNSTransaction in Own Shares
15th Nov 20241:04 pmRNSNet Asset Value(s)
14th Nov 20245:21 pmRNSTransaction in Own Shares
14th Nov 202412:25 pmRNSNet Asset Value(s)
13th Nov 20245:22 pmRNSTransaction in Own Shares
13th Nov 202412:43 pmRNSNet Asset Value(s)
12th Nov 20245:24 pmRNSTransaction in Own Shares
12th Nov 202412:05 pmRNSNet Asset Value(s)
12th Nov 20248:56 amRNSPortfolio disclosure
11th Nov 20245:26 pmRNSTransaction in Own Shares
11th Nov 20242:17 pmRNSGearing disclosure
11th Nov 20241:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.